JNS.jpgThe November issue of the Journal of the Neurological Sciences Vol 485 is now available online.


Click here to access


Issue highlights

Towards evidence-based policies to strengthen acute stroke care in low-middle-income countries

  • There is a disproportionate burden of stroke in most parts of LMICs
  • Uptake of new effective interventions for acute stroke care remains limited.
  • Reconfiguration of health systems should be prioritised to optimise access to quality acute stroke care
  • Contextually appropriate approaches are critical in reconfiguring health systems to improve care

Neurological research & training after the easing of lockdown in countries impacted by COVID-19

With the easing of lockdown restrictions following declining rates of COVID-19 infections, the biggest challenge for neurologists and neuroscientists in the most severely affected countries is likely to be the protracted transition to a new normal. While the neurological impact of COVID-19 is now well recognized, especially among healthcare workers and vulnerable groups the challenges of restarting clinical and laboratory research, and allowing clinical study coordinators and laboratory staff back on-site are enormous and deserve greater attention.

Multiple sclerosis in Pakistan: Current status and future perspective

  • Estimated prevalence of MS in Pakistan may be 10 per 100,000 population.
  • Preponderance to MS include a female gender, mean age of onset in the third decade of life and similar risk factors including viral infections, smoking, and vitamin D deficiency, as well as genetic risk factors
  • Relapsing-remitting multiple sclerosis (RRMS) is the most common disease pattern seen in Pakistan
  • Limited data available for MS in Pakistan
  • Disease modifying treatments use is limited due to awareness, limited availability of neurologists and cost of treatment

New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?

  • ALS is a model to further develop telemedicine and new technologies, speeded up by COVID-19 pandemic.
  • Telemedicine has already been successfully implemented in some ALS centres, being feasible, safe, with positive cost-benefit aspects.
  • New technologies facilitating communication, mobility, environment interaction/ control and cognitive assessment are already available in ALS.
  • The control of the new technologies by telemedicine will further promote the care to ALS patients.
  • Legal issues deserve more attention in the near future.